Celcuity (CELC)
(Delayed Data from NSDQ)
$15.77 USD
-0.56 (-3.43%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $15.77 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
CELC 15.77 -0.56(-3.43%)
Will CELC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CELC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CELC
Why Celcuity (CELC) Might Surprise This Earnings Season
Wall Street Analysts Think Celcuity, Inc. (CELC) Could Surge 359%: Read This Before Placing a Bet
CELC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CELC
Cisco, Walmart report quarterly earnings beats: Morning Buzz
Celcuity price target lowered by $1 at Stifel, here's why
Analysts Offer Insights on Healthcare Companies: TransCode Therapeutics (RNAZ) and Celcuity (CELC)
Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)
Cisco, Walmart report quarterly earnings beats: Thursday Buzz